| Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies RA Alshaikh, C Waeber, KB Ryan Advanced Drug Delivery Reviews 187, 114342, 2022 | 35 | 2022 |
| Eutexia for enhanced dissolution rate and anti-inflammatory activity of nonsteroidal anti-inflammatory agents: Caffeine as a melting point modulator RA Alshaikh, EA Essa, GM El Maghraby International journal of pharmaceutics 563, 395-405, 2019 | 34 | 2019 |
| Preparation of stabilized submicron fenofibrate crystals on niacin as a hydrophilic hydrotropic carrier RA Alshaikh, EA Essa, GM El Maghraby Pharmaceutical Development and Technology 25 (2), 168-177, 2020 | 8 | 2020 |
| Sphingosine 1-phosphate, a potential target in neovascular retinal disease RA Alshaikh, KB Ryan, C Waeber British Journal of Ophthalmology 106 (9), 1187-1195, 2022 | 7 | 2022 |
| A cross sectional study of the risk factors of hepatitis C infection in North Egypt SS Mandoh, K Ayman, A Elbardakheny, H Raaft, AA Ibrahim, RA Alshaikh, ... Virusdisease 32 (1), 22-28, 2021 | 7 | 2021 |
| Co-processing of Atorvastatin and Ezetimibe for Enhanced Dissolution Rate: In Vitro and In Vivo Correlation MF Arafa, RA Alshaikh, MM Abdelquader, GM El Maghraby AAPS PharmSciTech 22, 1-11, 2021 | 5 | 2021 |
| Siponimod as a novel inhibitor of retinal angiogenesis: in vitro and in vivo evidence of therapeutic efficacy RA Alshaikh, RGE Zaki, RAS El Din, KB Ryan, C Waeber Journal of Pharmacology and Experimental Therapeutics 386 (2), 224-241, 2023 | 1 | 2023 |
Gamal El MaghrabyProfessor of pharmaceutical technology, Faculty of pharmacy, Tanta University, EgyptVerified email at pharm.tanta.edu.eg
